logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
J

Jane Meisel

emory winship cancer institute
H指数:27
被引数:3,728

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Association between self-reported breast cancer knowledge and clinical trial participation in patients with triple-negative breast cancer

三阴性乳腺癌患者自报乳腺癌知识与临床试验参与之间的关系

Breast Cancer Research and Treatment
IF3
2026-07-300
PRE
Megan E. Tesch; Noah Graham; Craig Snow; Catherine E. Stever; Tonia S. Parker; Melinda Luo; Isabella G. Martino; Bridget Drummey; Sarina Virani; Katheryn Santos; Jad Bsat; Sean Ryan; Melissa E. Hughes; Eileen Wrabel; Nadine Tung; Steve Lo; Nisar Ahmad; Meredith Faggen; Natalie Sinclair; Maria Constantinou; Sarah Sinclair; Jane L. Meisel; Tari A. King; Elizabeth A. Mittendorf; Nabihah Tayob; Nancy U. Lin; Ann H. Partridge; Eric P. Winer; Sara M. Tolaney; Ana C. Garrido-Castro
Improving CDK4/6 inhibitors adherence in breast cancer using the CONnected CUstomized Treatment Platform (CONCURxP) mobile health intervention: Study protocol for ECOG-ACRIN EAQ221CD

使用CONnected CUstomized Treatment Platform (CONCURxP)移动健康干预方案改善乳腺癌中CDK4/6抑制剂的依从性：ECOG-ACRIN EAQ221CD研究方案

CONTEMPORARY CLINICAL TRIALS
IF1.9
2025-11-010
OAAI
Sadigh, Gelareh; Duan, Fenghai; Gareen, Ilana F.; Hancock, Judy; Sicks, Jorean D.; Thangarajah, Maryanne; Meisel, Jane L.; Torres, Mylin A.; Ramsey, Scott D.; Wolff, Antonio C.; Wagner, Lynne I.; Carlos, Ruth C.; Graetz, Ilana
Palbociclib with adjuvant endocrine therapy in early breast cancer: five-year follow up analysis of the global multicenter, open-label, randomized phase III PALLAS trial (ABCSG-42/AFT-05/PrE0109/BIG-14-13)

帕博西利联合辅助内分泌疗法在早期乳腺癌中的应用：全球多中心、开放标签、随机III期PALLAS试验（ABCSG-42/AFT-05/PrE0109/BIG-14-13）五年随访分析

Annals of Oncology
IF65.4
2025-10-170
OAAI
E.L. Mayer; D. Hlauschek; M. Gnant; P.J. O'Brien; M. Bellet-Ezquerra; M.P. Goetz; M. Ruiz-Borrego; A. Chan; K. Clifton; D. Egle; D. Lake; P. Cabrera; T. Mamounas; G. Pristauz-Telsnigg; Z. Dayao; M. Gil Gil; D. Cameron; T. Traina; P.G. Morris; D. Sabanathan; G. Rinnerthaler; J. Meisel; A. Prat; A.C. Wolff; L-M. Tseng; C. Isaacs; C.F. Singer; G. Rubovszky; T. Foukakis; J. Jassem; E.P. Winer; M. Vetter; J. Federmann; O. Metzger; C. Schurmans; E. Gauthier; D.R. Lu; C. Fesl; A. Dueck; A. DeMichele
Corrigendum to “Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

勘误：“Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial” [The Breast 83 (2025) 104547]

The Breast
IF0
2025-09-220
PREAI
Isabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
Real-world treatment patterns and clinical outcomes with tucatinib-based therapy in patients with HER2-positive metastatic breast cancer: analyses of two nationwide administrative health claims databases

基于tucatinib的疗法在HER2阳性转移性乳腺癌患者中的真实世界治疗模式与临床结局：两项全国性行政健康索赔数据库的分析

international journal of oncology
IF2.8
2025-08-060
OAAI
Carey Anders; Edward Neuberger; Naomi R. M. Schwartz; Karen Bartley; Shu Wang; Yutong Liu; Brian T. Pittner; Peter A. Kaufman; Jane Meisel
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial

POSITIVE试验中，预测乳腺癌患者为尝试生育而中断辅助内分泌治疗时生育力的激素因素

breast
IF0
2025-07-260
OAAI
Isabelle Demeestere; Samuel M. Niman; Ann H. Partridge; Daniela S. Diego; Roswitha Kammler; Monica Ruggeri; Marco Colleoni; Chikako Shimizu; Cristina Saura; Karen A. Gelmon; Anna B. Saetersdal; Judith R. Kroep; Audrey Mailliez; Frederic Amant; Manuel Ruız-Borrego; Jeong Eon Lee; Akemi Kataoka; Janice M. Walshe; Junko Takei; Simona Borstnar; Virginia F. Borges; Christobel Saunders; Snezana Susnjar; Vesna Bjelic-Radisic; Fatima Cardoso; Jane Lowe Meisel; Jennifer F. Kawwass; Tanja Spanic; Sarra El-Abed; Martine Piccart; Larissa A. Korde; Aron Goldhirsch; Richard D. Gelber; Olivia Pagani; Hatem A. Azim; Fedro A. Peccatori
Circulating tumor DNA mutational landscape and dynamics after progression on a CDK4/6 inhibitor in the PACE phase II trial for metastatic HR-positive/HER2-negative breast cancer☆

循环肿瘤DNA突变景观和进展后使用CDK4/6抑制剂的动态变化：PACE II期临床试验中转移性HR阳性/HER2阴性乳腺癌☆

ESMO Open
IF8.3
2025-07-250
OAAI
R. Jeselsohn; J. Fu; Y. Ren; R. Mahtani; C. Ma; A. DeMichele; M. Cristofanilli; J. Meisel; K.D. Miller; Y. Abdou; E.C. Riley; R. Qamar; P. Sharma; S. Reid; N. Ko; Y. Liu; E. Gauthier; H.J. Burstein; M. DeMeo; M. Regan; S.M. Tolaney; E.L. Mayer
Gene expression associated with endocrine therapy resistance in estrogen receptor-positive breast cancer
SCIENTIFIC REPORTS
IF3.9
2025-02-280
OAAI
Jones, Veronica; Yin, Hongwei Holly; Yuan, Yate-Ching; Wang, Yongzhe; Li, Sierra Min; Aljaber, Dana; Sanchez, Angelica; Quinones, Christine; Schmolze, Dan; Yuan, Yuan; Mortimer, Joanne; Yee, Lisa; Kruper, Laura; Jovanovic-Talisman, Tijana; Tomsic, Jerneja; Sanchez, Nancy; Chavez, Tanya; O'Regan, Ruth M.; Khan, Qamar J.; Davis, Melissa; Kalinsky, Kevin; Meisel, Jane; Kittles, Rick; Rodriguez-Rodriguez, Lorna; Seewaldt, Victoria
TROPION-Breast04: a randomized phase III study of neoadjuvant datopotamab deruxtecan (Dato-DXd) plus durvalumab followed by adjuvant durvalumab versus standard of care in patients with treatment-naïve early-stage triple negative or HR-low/HER2-breast cancer

TROPION-Breast04：一项针对治疗初治早期三阴性或HR低表达/HER2阳性乳腺癌患者的新辅助达托妥单抗德鲁替康（Dato-DXd）联合度伐利尤单抗，随后进行辅助度伐利尤单抗与标准护理对照的随机III期研究

THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY
IF4.2
2025-02-051
OA
Heather L. McArthur; Sara M. Tolaney; Rebecca Dent; Peter Schmid; Jamil Asselah; Qiang Liu; Jane Lowe Meisel; Naoki Niikura; Yeon Hee Park; Gustavo Werutsky; Giampaolo Bianchini; Jay C. Andersen; Robert Kozarski; Nana Rokutanda; Barbara Pistilli; Sibylle Loibl
Effects of Lasofoxifene Versus Fulvestrant on Vaginal and Vulvar Symptoms in Patients With ESR1-Mutated, ER + /HER2-, Metastatic Breast Cancer From the ELAINE 1 Study

LASOFOXIFENE与FULVESTRANT对ESR1突变、ER+/HER2-转移性乳腺癌患者阴道和外阴症状的影响：来自ELAINE 1研究的结果

CLINICAL BREAST CANCER
IF2.5
2024-12-011
PRE
Goldfarb, Shari B.; Sammons, Sarah L.; Meisel, Jane L.; Pluard, Timothy J.; Jenkins, Simon N.; Komm, Barry S.; Carroll, Dominic; Portman, David J.
Datopotamab-deruxtecan in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trial

Datopotamab-deruxtecan治疗早期乳腺癌: 序贯多重分配随机I-SPY2.2 2期试验

NATURE MEDICINE
IF50
2024-09-141
PRE
Khoury, Katia; Meisel, Jane L.; Yau, Christina; Rugo, Hope S.; Nanda, Rita; Davidian, Marie; Tsiatis, Butch; Chien, A. Jo; Wallace, Anne M.; Arora, Mili; Rozenblit, Mariya; Hershman, Dawn L.; Zimmer, Alexandra; Clark, Amy S.; Beckwith, Heather; Elias, Anthony D.; Stringer-Reasor, Erica; Boughey, Judy C.; Nangia, Chaitali; Vaklavas, Christos; Omene, Coral; Albain, Kathy S.; Kalinsky, Kevin M.; Isaacs, Claudine; Tseng, Jennifer; Torres, Evanthia T. Roussos; Thomas, Brittani; Thomas, Alexandra; Sanford, Amy; Balassanian, Ronald; Ewing, Cheryl; Yeung, Kay; Sauder, Candice; Sanft, Tara; Pusztai, Lajos; Trivedi, Meghna S.; Outhaythip, Ashton; Li, Wen; Onishi, Natsuko; Asare, Adam L.; Beineke, Philip; Norwood, Peter; Brown-Swigart, Lamorna; Hirst, Gillian L.; Matthews, Jeffrey B.; Moore, Brian; Symmans, W. Fraser; Price, Elissa; Beedle, Carolyn; Perlmutter, Jane; Pohlmann, Paula; Shatsky, Rebecca A.; Demichele, Angela; Yee, Douglas; van't Veer, Laura J.; Hylton, Nola M.; Esserman, Laura J.

研究方向

暂未获取到该数据
X
Xiaoxian Li
H 指数:35论文数:279被引数:6,159
A
Angela DeMichele
H 指数:89论文数:736被引数:2.8万
T
Timothy Pluard
H 指数:33论文数:229被引数:6,448
E
Erica L. Mayer
H 指数:44论文数:362被引数:9,767
S
Sarah Sammons
H 指数:23论文数:210被引数:1,674
E
Erica Stringer-Reasor
H 指数:28论文数:170被引数:7,417
M
Mylin A. Torres
H 指数:32论文数:189被引数:3,481
S
Sara M. Tolaney
H 指数:83论文数:1,341被引数:3.6万
K
Kevin Kalinsky
H 指数:36论文数:221被引数:4,160
R
Ruth O’Regan
H 指数:55论文数:277被引数:1.5万